Cambrex Corp., a manufacturer of small molecule innovator and generic APIs, began a $5 million expansion of its lab facilities in Karlskoga, Sweden, to augment capability and capacity for process development and scale up, handling of potent substances, crystallization studies and solid phase characterization. Construction on the 600 m2 building is expected to be complete in 2Q19.   The expansion will create space for a new technical lab with walk-in hoods for large scale lab syntheses up to 10...